An Open-Label Pilot Study to Determine the Efficacy of Lopinavir/Ritonavir and Tenofovir DF in the Treatment of HIV-Infected Patients Experiencing First Virologic Failure on a Non-nucleoside-Based Regimen
Available accessLetterFirst published online April, 2008
An Open-Label Pilot Study to Determine the Efficacy of Lopinavir/Ritonavir and Tenofovir DF in the Treatment of HIV-Infected Patients Experiencing First Virologic Failure on a Non-nucleoside-Based Regimen